Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Investing Activities: 2013-2019

Historic Cash from Investing Activities for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2019 value amounting to $103,000.

  • Soleno Therapeutics' Cash from Investing Activities rose 159.20% to $103,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $528,000, marking a year-over-year increase of 171.64%. This contributed to the annual value of -$225.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Soleno Therapeutics reported Cash from Investing Activities of $103,000 as of Q4 2019, which was down 76.64% from $441,000 recorded in Q3 2019.
  • In the past 5 years, Soleno Therapeutics' Cash from Investing Activities ranged from a high of $441,000 in Q3 2019 and a low of -$1.3 million during Q3 2015.
  • For the 3-year period, Soleno Therapeutics' Cash from Investing Activities averaged around -$23,667, with its median value being -$5,000 (2018).
  • In the last 5 years, Soleno Therapeutics' Cash from Investing Activities slumped by 1,800.00% in 2016 and then soared by 8,920.00% in 2019.
  • Over the past 5 years, Soleno Therapeutics' Cash from Investing Activities (Quarterly) stood at -$31,777 in 2015, then spiked by 101.01% to $320 in 2016, then skyrocketed by 4,587.50% to $15,000 in 2017, then plummeted by 1,260.00% to -$174,000 in 2018, then spiked by 159.20% to $103,000 in 2019.
  • Its Cash from Investing Activities was $103,000 in Q4 2019, compared to $441,000 in Q3 2019 and -$6,000 in Q2 2019.